BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22037652)

  • 1. Comparison of different adjuvant radiotherapy approaches in childhood bladder/prostate rhabdomyosarcoma treated with conservative surgery.
    Heinzelmann F; Thorwarth D; Lamprecht U; Kaulich TW; Fuchs J; Seitz G; Ebinger M; Handgretinger R; Bamberg M; Weinmann M
    Strahlenther Onkol; 2011 Nov; 187(11):715-21. PubMed ID: 22037652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma.
    Buszek SM; Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27952. PubMed ID: 31397065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
    Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy.
    Cotter SE; Herrup DA; Friedmann A; Macdonald SM; Pieretti RV; Robinson G; Adams J; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1367-73. PubMed ID: 20934266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder function after conservative surgery and high-dose rate brachytherapy for bladder-prostate rhabdomyosarcoma.
    Lobo S; Gaze MN; Slater O; Hoskin P; Sands G; Sullivan T; Cho A; Eminowicz G; Smeulders N
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29574. PubMed ID: 35044080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brachytherapy Combined With Surgery for Conservative Treatment of Children With Bladder Neck and/or Prostate Rhabdomyosarcoma.
    Chargari C; Haie-Meder C; Guérin F; Minard-Colin V; de Lambert G; Mazeron R; Escande A; Marsolat F; Dumas I; Deutsch E; Valteau-Couanet D; Audry G; Oberlin O; Martelli H
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):352-359. PubMed ID: 28463154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
    Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
    Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment efficiency, outcome and surgical treatment problems in patients suffering from localized embryonal bladder/prostate rhabdomyosarcoma: a report from the Cooperative Soft Tissue Sarcoma trial CWS-96.
    Seitz G; Dantonello TM; Int-Veen C; Blumenstock G; Godzinski J; Klingebiel T; Schuck A; Leuschner I; Koscielniak E; Fuchs J;
    Pediatr Blood Cancer; 2011 May; 56(5):718-24. PubMed ID: 21370402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison of high-dose-rate brachytherapy and intensity-modulated radiation therapy as a boost to the prostate.
    Hermesse J; Biver S; Jansen N; Lenaerts E; Nickers P
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):269-76. PubMed ID: 19775833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dosimetric selectivity intercomparison of HDR brachytherapy, IMRT and helical tomotherapy in prostate cancer radiotherapy.
    Hermesse J; Biver S; Jansen N; Lenaerts E; De Patoul N; Vynckier S; Coucke P; Scalliet P; Nickers P
    Strahlenther Onkol; 2009 Nov; 185(11):736-42. PubMed ID: 19899007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.
    Trofimov A; Nguyen PL; Coen JJ; Doppke KP; Schneider RJ; Adams JA; Bortfeld TR; Zietman AL; Delaney TF; Shipley WU
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):444-53. PubMed ID: 17513063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy.
    Underwood T; Giantsoudi D; Moteabbed M; Zietman A; Efstathiou J; Paganetti H; Lu HM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):454-464. PubMed ID: 27084660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plan Selection in Proton Therapy of Locally Advanced Prostate Cancer with Simultaneous Treatment of Multiple Targets.
    Pilskog S; Abal B; Øvrelid KS; Engeseth GM; Ytre-Hauge KS; Hysing LB
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):630-638. PubMed ID: 31759076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico comparison of whole pelvis intensity-modulated photon versus proton therapy for the postoperative management of prostate cancer.
    Gogineni E; Cruickshank IK; Chen H; Halthore A; Li H; Deville C
    Acta Oncol; 2023 Jun; 62(6):642-647. PubMed ID: 37345868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvements in the Treatment of Patients Suffering from Bladder-Prostate Rhabdomyosarcoma: A Report from the CWS-2002P Trial.
    Seitz G; Fuchs J; Sparber-Sauer M; Leuschner I; Godzinski J; Klingebiel T; Schuck A; Martus P; Dantonello TM; Koscielniak E
    Ann Surg Oncol; 2016 Nov; 23(12):4067-4072. PubMed ID: 27387676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Image-Guided Intensity-Modulated Radiotherapy and Low-dose Rate Brachytherapy with or without External Beam Radiotherapy in Patients with Localized Prostate Cancer.
    Tsubokura T; Yamazaki H; Masui K; Sasaki N; Shimizu D; Suzuki G; Nakamura S; Yamada K; Okihara K; Shiraishi T; Yoshida K; Nishikawa T; Okabe H
    Sci Rep; 2018 Jul; 8(1):10538. PubMed ID: 30002393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
    Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative intensity-modulated brachytherapy for refractory orbital rhabdomyosarcomas in children.
    Strege RJ; Kovács G; Meyer JE; Holland D; Claviez A; Mehdorn MH;
    Strahlenther Onkol; 2009 Dec; 185(12):789-98. PubMed ID: 20013088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rhabdomyosarcoma of the prostate and bladder in a child: radical or conservative surgery?].
    Carvajal Busslinger MI; Plaschkes J
    Helv Chir Acta; 1994 Dec; 60(6):1097-100. PubMed ID: 7875988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
    Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.